WuXi AppTec Co., Ltd. (SHA: 603259)

China flag China · Delayed Price · Currency is CNY
55.86
+2.86 (5.40%)
Jan 20, 2025, 11:30 AM CST
-25.41%
Market Cap 160.34B
Revenue (ttm) 38.50B
Net Income (ttm) 8.06B
Shares Out 2.89B
EPS (ttm) 2.75
PE Ratio 20.39
Forward PE 14.82
Dividend 1.02 (1.93%)
Ex-Dividend Date Jun 26, 2024
Volume 46,036,555
Average Volume 29,369,126
Open 53.62
Previous Close 53.00
Day's Range 53.62 - 56.69
52-Week Range 36.36 - 75.38
Beta 0.82
RSI 57.44
Earnings Date Mar 18, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 41,116
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2023, WuXi AppTec's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.

Financial Statements

News

There is no news available yet.